Literature DB >> 23750889

Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies.

Andrea Olmos1, Lorenza Díaz, Euclides Avila, David Barrera, Rebeca López-Marure, Benjamín Biruete, Fernando Larrea, Ali Halhali.   

Abstract

The aim of this study was to investigate the associations between insulin-like growth factor I (IGF-I) with vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sFlt-1) in umbilical serum and to study the effects of IGF-I upon sFlt-1 synthesis in human umbilical vein endothelial cells (HUVEC) in normotensive (NT) and preeclamptic (PE) pregnancies. As compared with the NT group, umbilical serum IGF-I and VEGF levels were lower in the PE group, while sFlt-1 concentrations were higher. Levels of sFlt-1 correlated with IGF-I in the NT group and with VEGF in the PE group. Basal concentration of sFlt-1 in HUVEC culture media was higher in the PE group. IGF-I stimulated sFlt-1 synthesis only in the NT group. In summary, umbilical serum sFlt-1 is associated with IGF-I in normotensive pregnancy and with VEGF in preeclampsia. IGF-I stimulates sFlt-1 synthesis in endothelial cells in normotensive but not in PE pregnancies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23750889     DOI: 10.3109/08977194.2013.802692

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  8 in total

1.  Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study.

Authors:  Stephannie Baehl Voller; Susanne Chock; Linda M Ernst; Emily Su; Xin Liu; Kathryn N Farrow; Karen K Mestan
Journal:  Early Hum Dev       Date:  2014-01-27       Impact factor: 2.079

2.  Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia.

Authors:  Kellen Hirsch; Elizabeth Taglauer; Gregory Seedorf; Carly Callahan; Erica Mandell; Carl W White; Stella Kourembanas; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

3.  Antenatal mesenchymal stromal cell extracellular vesicle treatment preserves lung development in a model of bronchopulmonary dysplasia due to chorioamnionitis.

Authors:  Alison N Abele; Elizabeth S Taglauer; Maricar Almeda; Noah Wilson; Abigail Abikoye; Gregory J Seedorf; S Alex Mitsialis; Stella Kourembanas; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-08       Impact factor: 5.464

4.  rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia.

Authors:  Gregory Seedorf; Christina Kim; Bradley Wallace; Erica W Mandell; Taylor Nowlin; Douglas Shepherd; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

Review 5.  Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic Pregnancies.

Authors:  David Barrera; Lorenza Díaz; Nancy Noyola-Martínez; Ali Halhali
Journal:  Nutrients       Date:  2015-08-04       Impact factor: 5.717

6.  Fetal Vegf Genotype is More Important for Abortion Risk than Mother Genotype.

Authors:  Sinem Atik Yalcintepe; Fatma Silan; Servet Ozden Hacivelioglu; Ahmet Uludag; Emine Cosar; Ozturk Ozdemir
Journal:  Int J Mol Cell Med       Date:  2014

Review 7.  Vitamin D and the Promotion of Long-Term Metabolic Health from a Programming Perspective.

Authors:  Saranya Palaniswamy; Dylan Williams; Marjo-Riitta Järvelin; Sylvain Sebert
Journal:  Nutr Metab Insights       Date:  2016-02-01

8.  Are the Cognitive Alterations Present in Children Born From Preeclamptic Pregnancies the Result of Impaired Angiogenesis? Focus on the Potential Role of the VEGF Family.

Authors:  Evelyn Lara; Jesenia Acurio; José Leon; Jeffrey Penny; Pablo Torres-Vergara; Carlos Escudero
Journal:  Front Physiol       Date:  2018-11-14       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.